Answers are grounded in this paper and cite their sources.
Accurate detection of dopamine (DA), a vital catecholamine neurotransmitter, is crucial for evaluating neurological functions and diagnosing related disorders. To address the challenges posed by complex biological matrices and trace DA concentrations, a robust fluorescent sensor was constructed by integrating molecularly imprinted polymers (MIPs) with ZIF-8-encapsulated CsPbBr 3 perovskite quantum dots (CsPbBr 3 @ZIF-8@MIPs). In this rational design, the ZIF-8 shell serves as a protective barrier, effectively preventing CsPbBr 3 from degradation in polar solvents, while the surface-imprinted layer provides high-affinity and selective recognition sites for DA. The sensor exhibits a favorable linear response in the range of 5–400 nM, with an ultralow detection limit of 4.85 nM and a rapid response within 30s. When applied to clinical serum samples from Parkinson’s disease patients, the sensor achieved satisfactory recoveries ranging from 96.83% to 109.72%, showing high consistency with the results obtained by high-performance liquid chromatography (HPLC). This work provides a reliable strategy for DA detection and demonstrates promising potential for biomedical sensing and clinical diagnosis.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: